Literature DB >> 6111419

The Role of the poly(A) sequence in mammalian messenger RNA.

G Brawerman.   

Abstract

The poly(A) sequence is added to 3' termini of nuclear RNA segments destined to become part of the mRNA, and may play an essential role in the selection of these segments. It appears to be required for at least some of the splicing events involved in mRNA processing. In the cytoplasm, the poly(A) segment is the target of a degradation process which causes its gradual shortening, and leads to a heterogeneous steady-state poly(A)-size distribution. Complete loss of the poly(A) is probably followed by inactivation of the mRNA, since chains depleted of poly(A) do not accumulate in the cells. A role for this sequence in the promotion of mRNA stability is suggested by the behavior of globin mRNA depleted of poly(A) after injection into frog oocytes. The poly(A) shortening process may be part of the mRNA inactivation mechanism, as indicated by the greater sensitivity to degradation of the poly(A) of some short-lived mRNAs. However, the stochastic mRNA decay implies that new and old mRNA chains, with long and short poly(A) segments, respectively are equally susceptible to inactivation. The poly(A)-lacking histone mRNAs are stable only in cells engaged in DNA replication. Present knowledge favors a role for poly(A) in the control of mRNA stability. Loss of this sequence could be controlled through modulation of poly(A)-protein interactions or through masking of a sequence directly adjacent to the poly(A). In the nucleus, the poly(A) sequence could also serve as stabilizing agent, but, in addition, it might interact with the splicing machinery.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6111419     DOI: 10.3109/10409238109114634

Source DB:  PubMed          Journal:  CRC Crit Rev Biochem        ISSN: 0045-6411


  73 in total

Review 1.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Degradation of a developmentally regulated mRNA in Xenopus embryos is controlled by the 3' region and requires the translation of another maternal mRNA.

Authors:  P Bouvet; J Paris; M Phillippe; H B Osborne
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 3.  Mechanisms of deadenylation-dependent decay.

Authors:  Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-09-15       Impact factor: 9.957

Review 4.  Tales of Detailed Poly(A) Tails.

Authors:  Angela L Nicholson; Amy E Pasquinelli
Journal:  Trends Cell Biol       Date:  2018-11-29       Impact factor: 20.808

5.  Catalytic core of alphavirus nonstructural protein nsP4 possesses terminal adenylyltransferase activity.

Authors:  Shailly Tomar; Richard W Hardy; Janet L Smith; Richard J Kuhn
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Comparison of the expression of two highly homologous members of the soybean ribulose-1,5-bisphosphate carboxylase small subunit gene family.

Authors:  B W Shirley; D P Ham; J F Senecoff; S L Berry-Lowe; L L Zurfluh; D M Shah; R B Meagher
Journal:  Plant Mol Biol       Date:  1990-06       Impact factor: 4.076

7.  Characterization and sequence of a cDNA clone of gamma-glutamyltranspeptidase.

Authors:  J Coloma; H C Pitot
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

8.  Isolation of genomic and cDNA clones encoding bovine poly(A) binding protein II.

Authors:  A Nemeth; S Krause; D Blank; A Jenny; P Jenö; A Lustig; E Wahle
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

Review 9.  Deadenylation and P-bodies.

Authors:  Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  Cloning of cDNA encoding the pre-beta subunit of mouse thyrotropin.

Authors:  J A Gurr; J F Catterall; I A Kourides
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.